Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MENS will decline by -27.75% over the next 2 Weeks and hit $1.99 by Tuesday, March 10, 2026. In that time frame, MENS's share price is expected to range between $1.65 and $2.36.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 10, 2026 | 1.65 | 1.99 | 2.36 |
| Mar 9, 2026 | 1.62 | 1.96 | 2.33 |
| Mar 6, 2026 | 1.88 | 2.24 | 2.58 |
| Mar 5, 2026 | 1.93 | 2.29 | 2.63 |
| Mar 4, 2026 | 2.00 | 2.37 | 2.73 |
| Mar 3, 2026 | 2.03 | 2.38 | 2.73 |
| Mar 2, 2026 | 1.98 | 2.35 | 2.71 |
| Feb 27, 2026 | 2.25 | 2.62 | 2.97 |
| Feb 26, 2026 | 2.33 | 2.67 | 3.03 |
| Feb 25, 2026 | 2.41 | 2.75 | 3.14 |
MENS shares fell -12.32% in Wednesday, February 25, 2026's trading session, dropping from a previous close of $2.76 to move at $2.42. The stock demonstrated notable intraday movement (see MENS's key stats for a full breakdown), fluctuating between $2.42 and $2.83, a +17.06% trading range. While recent weeks have seen some volatility, MENS has managed to secure a +65.75% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 286.97K shares changing hands, 390.49K fewer than the previous session. This amounted to $694.47K in total market activity.
Will MENS Continue Its Downward Trend?
According to analyst ratings and projections for MENS, Jyong Biotech Ltd. Ordinary Shares shares are anticipated to decrease by -2.41%, potentially reaching $2.36 per share by March 10, 2026. Short-term technical indicators for MENS currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 18 negative trading days within the past 30 sessions. Based on the MENS stock forecast, now is not the best time to buy MENS stock because its current trading price is +21.36% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MENS covering social and institutional perspectives.
MENS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MENS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 33.40% to 52.69%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 39.58%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 47.74%, maintains a neutral outlook for the long term. Insights into MENS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Jyong Biotech Ordinary Shares Short-Term Forecasts
MENS Forecast For Next 5 Days
Our algorithm anticipates Jyong Biotech Ordinary Shares (MENS) stock could hit $0.07 by Mar 04, 2026. This represents a -97.26% fall from today's price, following a -8.43% change over the past five days.
MENS Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Jyong Biotech Ltd. Ordinary Shares (MENS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.04, which would mean a -98.35% decrease from the current price of $2.42. Projections for this period range from a high of $2.40 to a low of $0.00.
MENS Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Jyong Biotech Ordinary Shares's price over the next three months point to a drop. MENS stock is expected to peak at $4.20 on Feb 26, 2026 before potentially dipping to $0.00 on May 25, 2026. On average, MENS is likely to trade around $0.86 in the coming 90 days.
Jyong Biotech Ordinary Shares Stock Forecast 2025
Based on our predictive models, Jyong Biotech Ordinary Shares (MENS) is expected to trade between $0.00 and $4.20 throughout 2026. This would result in an average price of $0.25, potentially offering investors a -89.67% return from current levels.
Jyong Biotech Ltd. Ordinary Shares Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Jyong Biotech Ltd. Ordinary Shares (MENS) is positioned to show a strong performance in February 2026. The price is predicted to move between $2.10 and $4.20, settling at an average of $2.98. This could translate to a +23.14% gain.
March 2026
Based on current market signals, Jyong Biotech Ltd. Ordinary Shares is projected to trend march 2026. We forecast a trading range from $0.00 to $3.57, with a likely average price of $1.62. Investors could expect a potential return of -33.06%.
April 2026
Our predictive algorithms indicate Jyong Biotech Ltd. Ordinary Shares stock may see a shift in April 2026. The expected range spans $0.00–$1.77, with an average target of $0.46. This represents a cautious outlook and a possible loss of -80.99%.
May 2026
Analyzing established trends, Jyong Biotech Ltd. Ordinary Shares looks set to move in May 2026. Projections place the stock between $0.00 and $1.33, averaging around $0.14. This suggests a -94.21% loss from current levels.
June 2026
Market indicators suggest Jyong Biotech Ltd. Ordinary Shares could experience notable changes during June 2026. Prices could fluctuate within $0.00 to $1.21, with a midpoint forecast of $0.03. The stock might deliver a -98.76% loss.
July 2026
Forecasting for July 2026, models estimate that Jyong Biotech Ltd. Ordinary Shares may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.13, averaging $0.01. This signals a cautious trajectory with potential returns around -99.59%.
August 2026
According to our latest forecast models, Jyong Biotech Ltd. Ordinary Shares (MENS) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $1.06, settling at an average of $0.01. This could translate to a -99.59% loss.
September 2026
Based on current market signals, Jyong Biotech Ltd. Ordinary Shares is projected to trend september 2026. We forecast a trading range from $0.00 to $1.11, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
October 2026
Our predictive algorithms indicate Jyong Biotech Ltd. Ordinary Shares stock may see a shift in October 2026. The expected range spans $0.00–$1.12, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
November 2026
Analyzing established trends, Jyong Biotech Ltd. Ordinary Shares looks set to move in November 2026. Projections place the stock between $0.00 and $1.10, averaging around $0.00. This suggests a -100.00% loss from current levels.
December 2026
Market indicators suggest Jyong Biotech Ltd. Ordinary Shares could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $1.10, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
January 2027
Forecasting for January 2027, models estimate that Jyong Biotech Ltd. Ordinary Shares may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.15, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
February 2027
According to our latest forecast models, Jyong Biotech Ltd. Ordinary Shares (MENS) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $1.25, settling at an average of $0.00. This could translate to a -100.00% loss.
MENS's history of dividends and stock splits also plays a role in long-term investor confidence.

